Researchers at Albert Einstein College of Medicine Receive $2.6 Million NIH Grant to Develop Targeted Cancer Immunotherapies

October 19, 2016—(BRONX, NY)—The National Institutes of Health has awarded two co-investigators atAlbert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.
Source: Einstein News - Category: Universities & Medical Training Source Type: news